FDA Selects Interim Director For Office Of Generic Drugs

Law360, New York (March 19, 2013, 5:05 PM EDT) -- The U.S. Food and Drug Administration has named a new acting director of its Office of Generic Drugs, selecting former head of the agency's women's health office Kathleen Uhl to the position on Tuesday while the FDA searches for someone to permanently fill the job.

Uhl steps into her new role less than a week after the previous head of the agency's generic-drug arm resigned, claiming that an upcoming restructuring of the agency would direct resources away from his areas of interest and prevent him from...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.